Alan Ashworth
Professor of Molecular Biology & Director,
The Breakthrough Breast Cancer Research Centre, ICR,
The GMEC Cluster Committee provides scientific strategy and direction to the company. The Cluster Committee is chaired by Jim Hagan, CEO. Cluster Committee meetings are also attended by Sir Keith Peters (Chairman), Board members Dr David Gauden (GE) and Mike Standing (Senior Partner Monitor Group).

Professor of Molecular Biology & Director,
The Breakthrough Breast Cancer Research Centre, ICR,

Vice Principal (Health),
King's College London

Head,
Medical Sciences Division,
Oxford University

Regius Professor of Physic,
School of Clinical Medicine,
Cambridge University

Principal,
Faculty of Medicine,
Imperial College London

Head,
Medical School,
University College London

Executive Director,
R&D,
Pfizer

Senior Vice President,
Immunoinflammation CEDD,
GlaxoSmithKline

Chief Executive Officer,
South London and Maudsley NHS Foundation Trust
Operations: Paula Brady